USP Comment Letter: Submitted to FDA and OMB on Final Rule on Naming Guidance (2017)

Submitted on February 17, 2017 - USP Comment Letter to FDA's Final Guidance, Nonproprietary Naming of Biological Products (Final Guidance). Docket No. FDA2013-D-1543.

USP-comments-to-OMB -on-Final-Rule-on-Naming-Guidance.pdf (2.61 MB)